50,893 Shares in Sotera Health (NASDAQ:SHC) Purchased by Wealth Enhancement Advisory Services LLC

Wealth Enhancement Advisory Services LLC acquired a new position in shares of Sotera Health (NASDAQ:SHC) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm acquired 50,893 shares of the company’s stock, valued at approximately $850,000.

A number of other hedge funds have also modified their holdings of SHC. CWM LLC grew its stake in Sotera Health by 86.1% in the second quarter. CWM LLC now owns 2,146 shares of the company’s stock valued at $25,000 after purchasing an additional 993 shares in the last quarter. GAMMA Investing LLC grew its stake in Sotera Health by 125.0% in the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after purchasing an additional 1,660 shares in the last quarter. Point72 DIFC Ltd grew its stake in Sotera Health by 556.6% in the second quarter. Point72 DIFC Ltd now owns 6,540 shares of the company’s stock valued at $78,000 after purchasing an additional 5,544 shares in the last quarter. Acadian Asset Management LLC grew its stake in Sotera Health by 728.0% in the second quarter. Acadian Asset Management LLC now owns 9,381 shares of the company’s stock valued at $111,000 after purchasing an additional 8,248 shares in the last quarter. Finally, Sandia Investment Management LP bought a new position in Sotera Health in the first quarter valued at approximately $120,000. 91.03% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

SHC has been the subject of a number of analyst reports. Barclays raised their price target on Sotera Health from $14.00 to $17.00 and gave the company an “overweight” rating in a research note on Tuesday, August 6th. Citigroup lifted their target price on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research note on Wednesday. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $17.00 target price on shares of Sotera Health in a research note on Tuesday, August 6th. Two investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $16.50.

Sotera Health Stock Performance

Shares of NASDAQ SHC opened at $16.11 on Thursday. The company has a current ratio of 2.93, a quick ratio of 2.59 and a debt-to-equity ratio of 5.46. Sotera Health has a 12 month low of $10.71 and a 12 month high of $17.44. The stock has a 50 day moving average of $15.96 and a 200-day moving average of $13.69. The company has a market capitalization of $4.56 billion, a P/E ratio of 115.07 and a beta of 2.08.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share for the quarter, missing the consensus estimate of $0.18 by ($0.01). The firm had revenue of $285.47 million for the quarter, compared to analyst estimates of $278.64 million. Sotera Health had a return on equity of 47.26% and a net margin of 3.65%. The business’s revenue for the quarter was up 8.5% on a year-over-year basis. During the same period in the previous year, the business posted $0.18 earnings per share. As a group, equities research analysts predict that Sotera Health will post 0.64 EPS for the current year.

Insider Buying and Selling

In related news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the sale, the director now directly owns 49,215,301 shares of the company’s stock, valued at approximately $739,705,974.03. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 55.12% of the stock is currently owned by insiders.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.